Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994: A report from the drug utilization sub-committee of the pharmaceutical benefits advisory committee

Medical Journal of Australia

Volumn 164, Issue 10, 1996, Pages 589-592

  McManus, Peter ^a,f   Primrose, John G ^b   Henry, David A ^c   Birkett, Donald J ^d   Lindner, Julie ^a   Day, Richard O ^e  

^a Drug Utilization Sub Committee   (Australia)

^b Dept of Health and Family Services   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d FLINDERS MEDICAL CENTRE   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; DIFLUNISAL; IBUPROFEN; INDOMETACIN; KETOPROFEN; MEFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PIROXICAM; SULINDAC; TENOXICAM; TIAPROFENIC ACID;

ADULT; ARTICLE; AUSTRALIA; BRONCHUS DISEASE; CARDIOVASCULAR DISEASE; DATA BASE; DRUG PREFERENCE; DRUG USE; EPIDEMIOLOGICAL DATA; GASTROINTESTINAL SYMPTOM; GOUT; HUMAN; KIDNEY DISEASE; LOW BACK PAIN; MAJOR CLINICAL STUDY; MARKETING; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PEPTIC ULCER; PRESCRIPTION; RHEUMATOID ARTHRITIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUSTRALIA; DRUG UTILIZATION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PEPTIC ULCER;

EID: 0029945856     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb122200.x     Document Type: Article

References (18)

1. Australian statistics on medicines 1991. Canberra: AGPS, 1992
2. Henry D. Assessing the benefits and risk of drugs: the example of NSAIDS. Aust Fam Physician 1990; 19: 378-383
3. Edmonds DJ, Dumbrell DM, Primrose JG. et al. Development of an Australian drug utilisation database: a report from the Drug Utilization Sub-committee of the Pharmaceutical Benefits Advisory Committee. PharmacoEconomics 1993; 3(6): 427-432.
4. Nordic Council on Medicines. Nordic statistics on medicines 1990-1992. Uppsala: Nordic Council on Medicines, 1993. (NLN Publication No. 34.)
5. World Health Organization Collaborating Centre for Drug Statistics Methodology Anatomical Therapeutic Chemical (ATC) classification index. Olso: WHO, January 1995.
6. Langman MJS, Weil J, Wainwright P. et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs Lancet 1994; 343: 1075-1078
7. Rodriguez L, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994; 343: 769-772.
8. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993; 105: 1078-1088.
9. Lecomte T, Paris V. Consommation de pharmacie en Europe, Allemagne, France, Italie, Royaume-Uni. Paris: Centre de Recherche d'Étude et Documentation en Économie de la Santé, 1994. (Publication No. 1048.)
10. Henry D, Robertson J. Nonsteroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales. Gastroenterology 1993; 104: 1083-1091.
11. Drug and Therapeutics Information Service (DATIS). Final report to the Department of Human Services and Health. Adelaide: Repatriation General Hospital, Daw Park, May 1994.
12. Sandhu GS, Day RO, Mant AR, et al. "Academic detailing" to influence non-steroidal anti-inflammatory drugs (NSAIDs) use in general practice. Aust Prescriber 1993; 16(Suppl. 1): 38-40.
13. Bradley JD, Brandt KD, Katz BR et al. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991; 325: 87-91
14. Bradley JD, Brandt KD, Katz BR et al. Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic. J Rheumatol 1992; 19:1950-1954.
15. Williams JH, Ward JR, Egger MJ, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993; 36: 1196-1206.
16. McManus P, Donnelly N, Henry D, et al. Prescription drug utilisation following patient copayment changes in Australia. Pharmacoepidemiol Drug Safety. In Press.
17. Analgesic Guidelines Sub-Committee of the Victorian Drug Usage Advisory Committee. Analgesic guidelines. 2nd ed. Melbourne: Victorian Medical Postgraduate Foundation, 1992.
18. De Jager J. Controversies of the new PBS NSAID listing: what is the best way to treat osteoarthritis? Curr Therapeut 1993; Aug: 9-11.